CNS Oncology
Title Abbreviation
CNS Oncol
Electronic ISSN
2045-0915
Therapeutic Area
Diagnostic Imaging, Health Economics/Outcomes Research, Molecular Medicine, Neurology, Nuclear Medicine, Oncology, Pain Management, Pathology, Patient Safety, Pharmacoeconomics, Surgery
Readership
Molecular Biologists, Neurologists, Oncologists, Pain Specialists, Pathologists, Patients, Pharmacologists, Physicians, Physicians - Medicine, Radiation Oncologists, Surgical Oncologists
Scope
CNS Oncology addresses key issues and current understanding in the diagnosis, staging and treatment of disease by exploring the best patient-centered clinical research and presenting this information both directly, as clinical findings, and in practice-oriented formats of direct relevance in the clinic.
CNS Oncology provides oncologists and other health professionals with the latest findings and opinions on reducing the burden of this widespread disease. Recent research findings and advances in clinical practice in the field are reported and analyzed by international experts, and the importance of the most recent advances in molecular biology are explained.
High-quality, methodologically sound papers are considered in the following areas:
Diagnosis and imaging. Staging. Epidemiology. Case reports/case series. Patient perspectives. Pharmacoeconomics and outcomes research. Pathology. Palliative Care. Radiotherapy. Chemotherapy. Surgical approaches. Systemic therapies. Adjuvant therapy. Biomarkers. Clinical trials – protocols and updates. Comparative effectiveness. Molecular biology of disease. Molecular diagnostics. Risk and prevention.
The journal welcomes unsolicited article proposals, including for the submission of original research, narrative and systematic reviews, and opinion pieces.
Sponsoring Association(s)
No associations affiliated with this journal
Publisher Name
Future Medicine Ltd.
Electronic Circulation
Submission to Acceptance
Acceptance to Online Publication
Rejection Rate
Frequency
Journal Contact
Author Submission Guidelines